Skip to main content

Table 1 Demographic and disease characteristics of patientsa at study entry

From: The prevalence of injection-site reactions with disease-modifying therapies and their effect on adherence in patients with multiple sclerosis: an observational study

  IM IFNβ-1a
(n = 82)
SC IFNβ-1b
(n = 123)
SC IFNβ-1a
(n = 184)
SC GA
(n = 23)
Overall
(N = 412)
Mean age, years (SD) 44.7 (10.35) 45.9 (10.23) 43.2 (9.72) 43.1 (11.25) 44.3 (10.12)
Gender, female (%) 64 (78.0) 84 (69.4) 122 (66.7) 15 (65.2) 285 (69.7)
Mean duration of MS disease, years (SD) 9.9 (7.37) 10.0 (6.29) 8.6 (5.74) 9.5 (4.92) 9.3 (6.22)
Mean duration of treatment, years (SD) 5.5 (2.56) 6.8 (3.06) 5.5 (2.93) 5.6 (3.24) 5.9 (2.97)
  1. aThere were no statistically significant differences between the groups.